These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33935944)

  • 1. CSF and Serum Biomarkers of Cerebral Damage in Autoimmune Epilepsy.
    Nass RD; Akgün K; Dague KO; Elger CE; Reichmann H; Ziemssen T; Surges R
    Front Neurol; 2021; 12():647428. PubMed ID: 33935944
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevated plasma neurofilament light and glial fibrillary acidic protein in epilepsy versus nonepileptic seizures and nonepileptic disorders.
    Dobson H; Al Maawali S; Malpas C; Santillo AF; Kang M; Todaro M; Watson R; Yassi N; Blennow K; Zetterberg H; Foster E; Neal A; Velakoulis D; O'Brien TJ; Eratne D; Kwan P
    Epilepsia; 2024 Jul; ():. PubMed ID: 39032019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
    Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
    Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizures.
    Akel S; Asztely F; Banote RK; Axelsson M; Zetterberg H; Zelano J
    Epilepsia; 2023 Oct; 64(10):2690-2700. PubMed ID: 37469165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacokinetic and biomarker study of delayed-release dimethyl fumarate in subjects with secondary progressive multiple sclerosis: evaluation of cerebrospinal fluid penetration and the effects on exploratory biomarkers.
    Edwards KR; Kamath A; Button J; Kamath V; Mendoza JP; Zhu B; Plavina T; Woodward C; Penner N
    Mult Scler Relat Disord; 2021 Jun; 51():102861. PubMed ID: 33773271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
    Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and CSF biomarkers in asymptomatic patients during primary HIV infection: a randomized study.
    Calcagno A; Cusato J; Cinque P; Marchetti G; Bernasconi D; Trunfio M; Bruzzesi E; Rusconi S; Gabrieli A; Muscatello A; Antinori A; Ripamonti D; Gulminetti R; Antonucci M; Nozza S
    Brain; 2024 Aug; ():. PubMed ID: 39171829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum NFL and tau, but not serum UCHL-1 and GFAP or CSF SNAP-25, NPTX2, or sTREM2, correlate with delirium in a 3-year retrospective analysis.
    Piel JHA; Bargemann L; Leypoldt F; Wandinger KP; Dargvainiene J
    Front Neurol; 2024; 15():1356575. PubMed ID: 38566855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Score Based on NfL and Glial Markers May Differentiate Between Relapsing-Remitting and Progressive MS Course.
    Huss A; Otto M; Senel M; Ludolph AC; Abdelhak A; Tumani H
    Front Neurol; 2020; 11():608. PubMed ID: 32765393
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased CX3CL1 in cerebrospinal fluid and ictal serum t-tau elevations in migraine: results from a cross-sectional exploratory case-control study.
    Süße M; Kloetzer C; Strauß S; Ruhnau J; Overeem LH; Bendig M; Schulze J; Reuter U; Vogelgesang A; Fleischmann R
    J Headache Pain; 2024 Apr; 25(1):46. PubMed ID: 38561692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of serum UCHL-1 and S100-B levels in differentiate epileptic seizures from psychogenic attacks.
    Asadollahi M; Simani L
    Brain Res; 2019 Feb; 1704():11-15. PubMed ID: 30253122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL.
    Chen CH; Cheng YW; Chen YF; Tang SC; Jeng JS
    J Neuroinflammation; 2020 Apr; 17(1):124. PubMed ID: 32321529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid ubiquitin C-terminal hydrolase as a novel marker of neuronal damage after epileptic seizure.
    Li Y; Wang Z; Zhang B; Zhe X; Wang M; Bai J; Lin T; Zhang S
    Epilepsy Res; 2013 Feb; 103(2-3):205-10. PubMed ID: 22920679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum biomarkers of cerebral cellular stress after self-limiting tonic clonic seizures: An exploratory study.
    Nass RD; Akgün K; Elger C; Reichmann H; Wagner M; Surges R; Ziemssen T
    Seizure; 2021 Feb; 85():1-5. PubMed ID: 33360039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament light chain: A possible fluid biomarker in the intrahippocampal kainic acid mouse model for chronic epilepsy?
    Custers ML; Vande Vyver M; Kaltenböck L; Barbé K; Bjerke M; Van Eeckhaut A; Smolders I
    Epilepsia; 2023 Aug; 64(8):2200-2211. PubMed ID: 37264788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
    J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity.
    Högel H; Rissanen E; Barro C; Matilainen M; Nylund M; Kuhle J; Airas L
    Mult Scler; 2020 Feb; 26(2):210-219. PubMed ID: 30570436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Markers of Neurodegeneration Are Raised in Friedreich's Ataxia.
    Zeitlberger AM; Thomas-Black G; Garcia-Moreno H; Foiani M; Heslegrave AJ; Zetterberg H; Giunti P
    Front Cell Neurosci; 2018; 12():366. PubMed ID: 30425621
    [No Abstract]   [Full Text] [Related]  

  • 19. Brain-specific biomarkers in urine as a non-invasive approach to monitor neuronal and glial damage.
    Kohlhase K; Frank F; Wilmes C; Koerbel K; Schaller-Paule MA; Miles M; Betz C; Steinmetz H; Foerch C
    Eur J Neurol; 2023 Mar; 30(3):729-740. PubMed ID: 36409153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction.
    Vågberg M; Norgren N; Dring A; Lindqvist T; Birgander R; Zetterberg H; Svenningsson A
    PLoS One; 2015; 10(8):e0135886. PubMed ID: 26317831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.